Bright Minds Biosciences Inc. (DRUG:NASDAQ) rocketted at $2.89, a gain of 46%. On Thu, Aug 25, 2022, DRUG:NASDAQ hit a New 2-Week High of $2.89. From Thu, Aug 11, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Aug 18, 2022 at $4.75 with a volume of 119M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 95.31%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 45.96%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 38%
- Renovare Environmental Inc. (RENO:NASDAQ), 36.85%
- Vaccitech plc (VACC:NASDAQ), 31.98%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 29.14%
- Snowflake Inc. Class A (SNOW:NYSE), 23.07%
- MSP Recovery Inc. (MSPR:NASDAQ), 22.46%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 21.91%